Showing results (151-160 of 319) with videos related to
Sort By:
Pageof 32
Clinical Science and Molecular Medicine. Supplement|December 1, 1978
Labetalol in hypertensive patients with angina pectoris: beneficial effect of combined alpha- and beta-adrenoreceptor blockadeW F Lubbe, D A WhiteClinical Science and Molecular Medicine. Supplement|December 1, 1978
beta-Adrenoreceptor-blocking agents and lipid metabolismJ D England, A S Hua, J ShawClinical Science and Molecular Medicine. Supplement|December 1, 1978
The effect of established beta-adrenoreceptor-blocking therapy on the release of cytosolic and lysosomal enzymes after acute myocardial infarction in manE Welman, K M Fox, A P Selwyn, et al.Clinical Science and Molecular Medicine. Supplement|December 1, 1976
Effects of carotid occlusion and clonidine on renin secretion in anaesthetized dogsI A Reid, A JonesClinical Science and Molecular Medicine. Supplement|December 1, 1978
Implications of prostacyclin generation for modulation of vascular toneG J Dusting, S Moncada, K M Mullane, et al.Clinical Science and Molecular Medicine. Supplement|December 1, 1978
The role of prostaglandins in the pathogenesis of hypertensionC M MarkovClinical Science and Molecular Medicine. Supplement|December 1, 1976
Plasma renin concentration and the hypotensive effect of bendrofluazide and of atenololR Fagard, A Amery, J F Deplaen, et al.Clinical Science and Molecular Medicine. Supplement|December 1, 1976
Clinical evaluation of atenolol in hypertensionL Hansson, B E Karlberg, H Aberg, et al.Clinical Science and Molecular Medicine. Supplement|December 1, 1976
Clinical and haemodynamic study of atenolol (Tenormin) in essential hypertensionH A Jensen, K Rasmussen, N MosbaekClinical Science and Molecular Medicine. Supplement|December 1, 1976
Differential effects of acute and chronic beta-adrenoreceptor blockade on blood pressure and the renin-angiotensin-aldosterone system in essential hypertensionR Kolloch, K O Stumpe, H Vetter, et al.Pageof 32